4.1 Article

Four Cases of Suspected Levetiracetam-Induced Asymptomatic Rhabdomyolysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, General & Internal

Suspected Levetiracetam-Induced Rhabdomyolysis: A Case Report and Literature Review

Imran A. Moinuddin

AMERICAN JOURNAL OF CASE REPORTS (2020)

Article Medicine, General & Internal

Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)

Chengwen Teng et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)

Letter Clinical Neurology

Levetiracetam-induced rhabdomyolysis: the first Italian case

Eugenia Rota et al.

NEUROLOGICAL SCIENCES (2018)

Article Medicine, General & Internal

Rhabdomyolysis: A Rare Averse Effect of Levetiracetam

Vaibhav Rastogi et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2018)

Article Clinical Neurology

A case of rhabdomyolysis in which levetiracetam was suspected as the cause

Hisanao Akiyama et al.

EPILEPSY & BEHAVIOR CASE REPORTS (2014)

Review Medicine, General & Internal

Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review

Gashirai K. Mbizvo et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)

Review Medicine, General & Internal

The syndrome of rhabdomyolysis: Complications and treatment

Yiannis S. Chatzizisis et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2008)

Article Clinical Neurology

Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy

S. F. Berkovic et al.

NEUROLOGY (2007)

Article Multidisciplinary Sciences

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

BA Lynch et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)